tanshinone has been researched along with Pancreatic Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiu, TL; Su, CC | 1 |
| Su, CC | 1 |
| Chen, DR; Chien, SY; Chiu, TL; Huang, CY; Kuo, SJ; Su, CC | 1 |
3 other study(ies) available for tanshinone and Pancreatic Neoplasms
| Article | Year |
|---|---|
Tanshinone IIA increases protein expression levels of PERK, ATF6, IRE1α, CHOP, caspase‑3 and caspase‑12 in pancreatic cancer BxPC‑3 cell‑derived xenograft tumors.
Topics: Abietanes; Activating Transcription Factor 6; Animals; Antineoplastic Agents, Phytogenic; Caspase 12; Caspase 3; Cell Line, Tumor; eIF-2 Kinase; Endoplasmic Reticulum Stress; Endoribonucleases; Humans; JNK Mitogen-Activated Protein Kinases; Male; Mice; Mice, SCID; Pancreatic Neoplasms; Protein Serine-Threonine Kinases; Salvia miltiorrhiza; Transcription Factor CHOP; Transplantation, Heterologous; Up-Regulation | 2017 |
Tanshinone IIA can inhibit MiaPaCa‑2 human pancreatic cancer cells by dual blockade of the Ras/Raf/MEK/ERK and PI3K/AKT/mTOR pathways.
Topics: Abietanes; Apoptosis; Cell Line, Tumor; Cell Proliferation; Humans; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; raf Kinases; ras Proteins; Signal Transduction; TOR Serine-Threonine Kinases | 2018 |
Tanshinone IIA inhibits the growth of pancreatic cancer BxPC‑3 cells by decreasing protein expression of TCTP, MCL‑1 and Bcl‑xL.
Topics: Abietanes; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Biomarkers, Tumor; Caspase 3; Cell Line, Tumor; Down-Regulation; Humans; Myeloid Cell Leukemia Sequence 1 Protein; Pancreatic Neoplasms; Salvia miltiorrhiza; Tumor Protein, Translationally-Controlled 1; Up-Regulation | 2013 |